JPRN-jRCT2080221862未知3 期
Z-103 Phase III Clinical Study in patients with Taste Disorder - A placebo-controlled superiority study
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Patients diagnosed with the following three types.
- •1. Zinc-deficient taste disorder
- •2. Idiopathic taste disorder
- •3. Drug-induced taste disorder (with some exceptions)
排除标准
- •1. Central nervous system disorder
- •2. Peripheral neuropathy
- •3. Intraoral defect and salivary gland disorder
- •4. Psychiatric disorder
- •5. Systemic disorders that cause taste disorder
研究者
相似试验
暂停
1 期
TAS0313 Phase I/II studySolid tumor (urothelial carcinoma, and so on)JPRN-jRCT2080223768Taiho Pharmaceutical Co., Ltd.130
未知
3 期
Confirmatory study of TA-8317 in patients with cancer breakthrough pain Open-label, crossover, comparative study using a comparator, morphine used as rescue medicatioCancer breakthrough painJPRN-jRCT2080220301Mitsubishi Tanabe Pharma Corporation
已完成
3 期
ENT103 Phase 3 Clinical Study in Patients with Suppurative Otitis Media with Persistent or Prolonged OtorrheaOtitis mediaJPRN-jRCT2080224658CEOLIA Pharma Co. Ltd200
招募中
3 期
Clinical evaluation of Diabepal tablet in comparison with Placebo tablet in Type 2 Diabetic PatientsCTRI/2014/10/005076Arjun Healthcare80
已完成
3 期
ong Term Follow-up Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)Spinal and Bulbar Muscular Atrophy (SBMA)JPRN-UMIN000001010Department of Neurology, Nagoya University School of Medicine152